Literature DB >> 24557936

Definition of primary and secondary glioblastoma--response.

Hiroko Ohgaki1, Peter Burger, Paul Kleihues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24557936      PMCID： PMC4695998          DOI： 10.1158/1078-0432.CCR-14-0238

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  1 in total

Review 1.  The definition of primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Clin Cancer Res       Date:  2012-12-03       Impact factor: 12.531
  1 in total
  14 in total

Review 1.  Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.

Authors:  Sameer Agnihotri; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2015-07-14       Impact factor: 12.300

2.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

3.  Circ_0001982 Up-regulates the Expression of E2F1 by Adsorbing miR-1205 to Facilitate the Progression of Glioma.

Authors:  Zhihui Ma; Jinyang Ma; Bojuan Lang; Fei Xu; Bo Zhang; Xiangyu Wang
Journal:  Mol Biotechnol       Date:  2022-08-22       Impact factor: 2.860

Review 4.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

5.  Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Authors:  Giuseppe Pelosi; Fabrizio Bianchi; Elisa Dama; Michele Simbolo; Andrea Mafficini; Angelica Sonzogni; Sara Pilotto; Sergio Harari; Mauro Papotti; Marco Volante; Gabriella Fontanini; Luca Mastracci; Adriana Albini; Emilio Bria; Fiorella Calabrese; Aldo Scarpa
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

6.  Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.

Authors:  Viviane A O Silva; Marcela N Rosa; Vera Miranda-Gonçalves; Angela M Costa; Aline Tansini; Adriane F Evangelista; Olga Martinho; Adriana C Carloni; Chris Jones; João Paulo Lima; Luiz F Pianowski; Rui Manuel Reis
Journal:  Invest New Drugs       Date:  2018-06-22       Impact factor: 3.850

7.  Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.

Authors:  Ajay Chaurasia; Sung-Hye Park; Jeong-Wook Seo; Chul-Kee Park
Journal:  J Korean Med Sci       Date:  2016-05-30       Impact factor: 2.153

Review 8.  Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Biomedicines       Date:  2021-05-30

Review 9.  Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change.

Authors:  Zhengqiu Zhou; Elochukwu Ibekwe; Yevgen Chornenkyy
Journal:  Antioxidants (Basel)       Date:  2018-01-17

10.  Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells.

Authors:  Zhendong Liu; Hongbo Wang; Yulong Jia; Jialin Wang; Yanbiao Wang; Lu Bian; Binfeng Liu; Xiaoyu Lian; Bo Zhang; Zhishuai Ren; Wang Zhang; Weiwei Dai; Yanzheng Gao
Journal:  Cancer Med       Date:  2021-07-15       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.